Comparison of Clinical and Laboratory Features and Treatment Options of 237 Symptomatic and Asymptomatic Children Infected with SARS-CoV-2 in the Early Phase of the COVID-19 Pandemic in Turkey

Little is known about the therapeutic use of hydroxychloroquine in pediatric patients with coronavirus disease 2019 (COVID-19). Here, we retrospectively retrieved data of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) PCR-positive pediatric patients from 20 hospitals in 8 Turkish citie...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Japanese Journal of Infectious Diseases 2021/07/31, Vol.74(4), pp.273-279
Hauptverfasser:	Soysal, Ahmet, Gönüllü, Erdem, Arslan, Hüseyin, Kibar, Büşra Sultan, Pop, Serdar, Yurttaş, Gözde Nur, Demirbacak, Hacer, Ünal, Füsun, Öktem, Sedat, Atıcı, Serkan, Şen, Arife Derda Yücel, Karabayır, Nalan, Karaböcüoğlu, Metin, group, PEDCOVID19 study
Format:	Artikel
Sprache:	eng
Schlagworte:	Abnormalities Asymptomatic Azithromycin Children Coronaviruses COVID-19 Dimers EKG Electrocardiography Epidemiology Health services Hydroxychloroquine Infectious Diseases Laboratories Life Sciences & Biomedicine Lymphocytes Medical treatment Oseltamivir Pandemics Patients Pediatrics Procalcitonin SARS-CoV-2 Science & Technology Severe acute respiratory syndrome coronavirus 2 Side effects Turkey Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!